18 Valuation Methods Compared: Which to Use When (India)

The Three Foundational Approaches to Valuation

Every valuation method falls under one of three globally recognised approaches. Understanding these approaches is essential before selecting a specific method, because Indian regulatory frameworks — whether Income Tax, FEMA, SEBI, or IBBI — all reference these foundational categories.

1. Income Approach

The income approach values a business based on its expected future economic benefits, discounted to present value at an appropriate risk-adjusted rate. This approach is most suitable when reliable financial projections are available and the business derives value primarily from its earning capacity rather than its assets.

Under Indian regulations, the income approach is the primary method prescribed under Rule 11UA(2)(b) of the Income Tax Rules (via DCF), the preferred method under FEMA NDI Rules for unlisted company share pricing, and one of the two mandatory methods under IBBI Regulation 35 (fair value / going concern value). The ICAI Valuation Standard 301 (Valuation of Intangible Assets) also emphasises the income approach for intangible asset valuation.

2. Market Approach

The market approach derives value from observable market data — either comparable publicly traded companies (Comparable Company Analysis) or comparable transactions (Comparable Transaction Analysis). This approach is strongest when sufficient market data exists and comparables are genuinely similar in size, geography, business model, and growth profile.

In India, the market approach is mandatory for listed companies under SEBI ICDR Regulations and is frequently used as a cross-check against DCF in IBBI and Rule 11UA valuations. However, the limited depth of Indian public markets and the scarcity of disclosed private transaction data make pure market-approach valuations challenging for unlisted SMEs.

3. Asset / Cost Approach

The asset approach values a business based on the net realisable value of its assets minus liabilities (NAV) or the cost to reproduce or replace its assets. This approach is most relevant for asset-heavy businesses (real estate, manufacturing, infrastructure), holding companies, investment vehicles, and businesses in liquidation or distress.

Rule 11UA(2)(a) prescribes NAV as the default method for unlisted share valuation under the Income Tax Act. IBBI Regulation 35 mandates liquidation value (a variant of the asset approach) as one of two required values in insolvency proceedings. The IBC valuation framework requires both liquidation value and fair value to enable the Committee of Creditors to make informed decisions.

The 18 Valuation Methods: Detailed Comparison

At Virtual Auditor, our valuation engine encompasses 18 distinct methods across the three approaches. Below, we examine each method in detail — its mechanics, regulatory acceptance, ideal use cases, limitations, and the Indian regulatory context in which it is most commonly applied.

Income Approach Methods

Method 1: Discounted Cash Flow (DCF)

Mechanics: Projects free cash flows (FCFF or FCFE) for an explicit forecast period (typically 5-10 years), then estimates a terminal value, and discounts everything to present value using WACC (for FCFF) or cost of equity (for FCFE). The India-specific WACC computation uses the 10-year G-sec yield (~7%) as the risk-free rate, Damodaran’s India equity risk premium (~8%), and Total Beta for unlisted companies.

Regulatory acceptance: Prescribed under Rule 11UA(2)(b) for Income Tax share premium valuation. Accepted under FEMA NDI Rules as the primary method for unlisted share pricing. Required under IBBI Regulation 35 as part of fair value determination. Referenced in SEBI ICDR Regulations for fairness opinions.

Ideal use cases: Growth-stage and mature companies with forecastable cash flows; companies raising equity (to justify share premium); cross-border investment pricing under FEMA; going-concern valuation in IBC proceedings.

Limitations: Highly sensitive to discount rate and terminal growth rate assumptions. Pre-revenue startups lack the cash flow history to build reliable projections. Requires robust financial modelling capability.

Our approach: We run Monte Carlo simulations on key DCF inputs — revenue growth, margins, WACC — to produce a probability distribution of values rather than a single point estimate. This addresses the inherent uncertainty in projections and has been well-received by tax authorities and FEMA regulators. See our detailed DCF methodology guide for India-specific WACC computation.

Method 2: Capitalisation of Earnings

Mechanics: Divides a normalised, sustainable earnings figure (typically EBITDA or net profit) by a capitalisation rate (required rate of return minus long-term growth rate). This is essentially a single-period DCF model — appropriate when the business has reached steady-state operations with stable, predictable earnings.

Regulatory acceptance: Accepted under IBBI Regulations as a fair value method. Recognised under ICAI Valuation Standards. Not explicitly prescribed under Rule 11UA but accepted as a supporting method in valuation reports filed with the Income Tax Department.

Ideal use cases: Mature, stable businesses with consistent earnings history (5+ years); professional services firms; franchise operations; utility-type businesses with regulated returns.

Limitations: Cannot capture growth trajectories — unsuitable for startups or high-growth companies. The single capitalisation rate must embed all future growth expectations, making it difficult to justify in rapidly evolving sectors. Earnings normalisation is subjective.

Method 3: Dividend Discount Model (DDM)

Mechanics: Values equity based on the present value of expected future dividends, discounted at the cost of equity. The Gordon Growth Model (single-stage DDM) divides expected dividends by (cost of equity minus dividend growth rate). Multi-stage DDMs accommodate changing growth phases.

Regulatory acceptance: Recognised under ICAI Valuation Standards and globally accepted (IVS, AICPA). Used in SEBI contexts for banking and financial institution valuations.

Ideal use cases: Listed companies with established dividend policies; banking and financial institutions (where cash flow to firm is difficult to estimate due to regulatory capital requirements); mature PSU stocks with consistent dividend payouts.

Limitations: Most Indian startups and growth companies do not pay dividends, rendering this method inapplicable. Dividend policy is a board decision and may not reflect underlying earning power. Tax treatment of dividends (post Finance Act 2020, dividends are taxable in the hands of shareholders) affects net dividend yields.

Method 4: Excess Earnings Method (Multi-Period)

Mechanics: Separates overall business earnings into returns attributable to tangible/monetary assets (using contributory asset charges) and “excess” earnings attributable to intangible assets. The excess earnings stream is then discounted to arrive at intangible asset value. Commonly used under Ind AS 103 (Business Combinations) for purchase price allocation.

Regulatory acceptance: Prescribed under ICAI Valuation Standard 301 for intangible asset valuation. Required for Ind AS 103 purchase price allocation. Accepted under IBBI Regulations for valuation of intangible assets in insolvency proceedings.

Ideal use cases: Intangible asset valuation — customer relationships, technology, brand value; purchase price allocation in M&A; impairment testing under Ind AS 36; valuations where intangibles form a significant portion of enterprise value (IT, pharma, consumer brands).

Limitations: Requires robust data on contributory asset returns. Highly dependent on assumptions about useful life and attrition rates of intangible assets. Complex to execute — requires specialised valuation expertise.

Method 5: Real Options Valuation

Mechanics: Applies option pricing theory (Black-Scholes or binomial lattice models) to value the flexibility embedded in business decisions — the option to expand, defer, abandon, or switch. Treats business opportunities as “options” with strike prices, expiry dates, and volatility parameters.

Regulatory acceptance: Recognised under ICAI Valuation Standards for complex instruments. Used in SEBI fairness opinions for contingent consideration structures. Accepted in NCLT proceedings for valuation of development-stage assets.

Ideal use cases: Natural resource companies (option to mine); pharma companies (option to commercialise drugs in development pipeline); real estate developers (option to develop land); convertible instrument valuation (embedded conversion options); ESOP valuation under Ind AS 102.

Limitations: Conceptually complex and difficult to explain to non-technical stakeholders. Volatility estimation for private companies is inherently approximate. Not widely understood by Indian tax authorities or tribunals.

Market Approach Methods

Method 6: Comparable Company Analysis (CCA)

Mechanics: Identifies publicly traded companies comparable to the subject company in terms of industry, size, geography, and growth profile. Derives valuation multiples (EV/EBITDA, EV/Revenue, P/E, P/B) from these comparables and applies them to the subject company’s financial metrics, with appropriate adjustments for size, liquidity, and growth differences.

Regulatory acceptance: Primary method under SEBI ICDR Regulations for pricing of listed company transactions. Accepted under IBBI Regulations as a fair value methodology. Used as a cross-check under Rule 11UA and FEMA valuations.

Ideal use cases: Companies in sectors with sufficient listed peers (IT services, banking, pharma, FMCG); secondary sale pricing; fairness opinions for related-party transactions under Section 188/177 of the Companies Act; benchmarking DCF conclusions.

Limitations: Indian listed market has limited depth in many sectors — finding genuine comparables for niche businesses is difficult. Public-to-private discount (30-40%) must be applied for unlisted companies. Small-cap listed companies may have illiquidity of their own, distorting multiples. Sectoral and cyclical factors can temporarily distort multiples.

Method 7: Comparable Transaction Analysis (CTA)

Mechanics: Analyses actual M&A transactions involving comparable companies to derive implied valuation multiples. Transaction multiples embed control premiums and synergy values, making them conceptually different from trading multiples. Sources include MCA filings, SEBI disclosures, VCCEdge, Tracxn, and global databases (Capital IQ, Mergermarket).

Regulatory acceptance: Accepted under IBBI Regulations, SEBI ICDR Regulations, and ICAI Valuation Standards. Particularly relevant for NCLT proceedings where fair value must reflect control transaction dynamics.

Ideal use cases: M&A pricing and fairness opinions; squeeze-out valuations under Section 236 of the Companies Act; buyback pricing under Section 68; valuation of controlling interests; PE/VC secondary transactions.

Limitations: Indian transaction databases are incomplete — many private company deals are not publicly disclosed. Transaction-specific synergies inflate multiples beyond standalone fair value. Vintage of transactions matters — a deal from a bull market may not reflect current conditions. Non-compete and earn-out structures distort headline transaction values.

Method 8: Market Price Method

Mechanics: For listed companies, uses the actual traded market price on recognised stock exchanges (BSE/NSE). SEBI prescribes specific lookback periods — typically the volume-weighted average price (VWAP) for the preceding 26 weeks or 60 trading days for various transaction types under SEBI (SAST) Regulations and SEBI (ICDR) Regulations.

Regulatory acceptance: Mandatory under SEBI regulations for open offers (SAST Regulations), preferential allotment pricing (ICDR Regulations), delisting (SEBI Delisting Regulations), and buyback pricing. The floor price under SEBI ICDR is typically the higher of the 26-week/2-week VWAP preceding the relevant date.

Ideal use cases: Exclusively for listed companies — all SEBI-regulated transactions; open offer pricing; preferential allotment; delisting; buyback; related-party transaction fairness assessments.

Limitations: Only applicable to listed companies. Thinly traded stocks may not reflect true fair value. Promoter-influenced buying/selling can distort prices. Market-wide events (crashes, rallies) affect prices irrespective of company fundamentals.

Method 9: Revenue Multiple Method

Mechanics: Applies an EV/Revenue multiple derived from comparable companies or comparable transactions to the subject company’s revenue. Particularly relevant for SaaS and technology companies where revenue is the most meaningful operating metric (given that many such companies are pre-EBITDA-positive).

Regulatory acceptance: Accepted under ICAI Valuation Standards as a market approach variant. Used in SEBI fairness opinions. Accepted as a cross-check method in Rule 11UA and FEMA valuation reports. Widely used in startup ecosystem transactions.

Ideal use cases: Early-stage and growth-stage SaaS companies with strong revenue growth but negative EBITDA; technology companies; marketplace businesses; subscription-model businesses where revenue quality (ARR, NRR) is the primary value driver.

Limitations: Revenue alone says nothing about profitability, cash flow generation, or unit economics. A 10x revenue multiple on a company burning cash is fundamentally different from the same multiple on a 30%-margin SaaS business. Must be used with careful analysis of comparable company margins and growth rates.

Asset / Cost Approach Methods

Method 10: Net Asset Value (NAV) Method

Mechanics: Restates all assets at fair market value, deducts all liabilities at settlement value, and arrives at the adjusted net asset value of the business. Goes beyond book value by incorporating market values of real estate, investments, and intangible assets not on the balance sheet.

Regulatory acceptance: Rule 11UA(2)(a) prescribes NAV as the default method for valuation of unquoted shares under Section 56(2)(x) of the Income Tax Act. Accepted under IBBI Regulations. Used under Companies Act Section 247 for asset-heavy companies.

Ideal use cases: Investment holding companies; real estate companies; asset-heavy manufacturing businesses; companies approaching liquidation; businesses where asset values significantly exceed earning capacity; shell companies and dormant entities.

Limitations: Ignores going-concern value and earnings potential. Intangible assets (brand, customer relationships, technology) are often not reflected on the balance sheet and must be separately valued. For technology or service companies, NAV significantly understates true business value.

Method 11: Liquidation Value Method

Mechanics: Estimates the net proceeds from selling all assets individually (not as a going concern) under forced-sale conditions, after deducting all liabilities, liquidation costs, and statutory dues. Typically yields the lowest value among all methods — it represents the floor value of the business.

Regulatory acceptance: Mandatory under IBBI Regulation 35 — the Registered Valuer must provide liquidation value alongside fair value in all CIRP proceedings. Used under IBC Section 35 for liquidation proceedings. Referenced in NCLT orders as the benchmark for minimum recovery by creditors.

Ideal use cases: IBC insolvency proceedings (mandatory); distressed asset sales; winding-up petitions; security enforcement by lenders; minimum reserve price determination for auction sales; SARFAESI Act proceedings.

Limitations: Forced-sale assumptions result in deep discounts (30-60% below fair value). Does not reflect going-concern value. Not appropriate as a primary method for operating businesses. Asset-by-asset liquidation ignores portfolio effects and operating synergies.

Method 12: Replacement Cost Method

Mechanics: Estimates the cost to replicate the business from scratch — rebuilding the asset base, recreating intangible assets (brand, customer base, technology), recruiting the workforce, and obtaining all licences and approvals. Adjusts for depreciation (physical, functional, economic obsolescence).

Regulatory acceptance: Recognised under ICAI Valuation Standards (particularly for intangible assets under Standard 301). Accepted under IBBI Regulations. Used for insurance valuations and government acquisition compensation under the Land Acquisition Act.

Ideal use cases: Specialised manufacturing facilities; technology platforms (cost to recreate the codebase); government acquisition compensation; insurance claim valuations; businesses with significant proprietary infrastructure; defence and aerospace companies.

Limitations: Extremely difficult to estimate — particularly for intangible assets like brand value or network effects. Does not account for time-to-build and opportunity cost. The cost of replication may exceed or fall short of the value the market places on the business. Functional and economic obsolescence adjustments are inherently subjective.

Hybrid and Specialised Methods

Method 13: Rule of Thumb / Industry Multiples

Mechanics: Uses industry-specific shorthand multiples that have developed through market practice — e.g., CA practices at 1-1.5x gross recurring fees, pharmacies at 1.5-2.5x annual revenue, hotels at per-key value, medical practices at EBITDA multiples specific to specialty.

Regulatory acceptance: Not prescribed under any Indian statute. Used as a sanity check or cross-reference in valuation reports. ICAI Valuation Standards acknowledge industry rules of thumb as supplementary indicators but caution against relying on them as the primary method.

Ideal use cases: Quick preliminary assessments; deal screening by PE/VC investors; SME acquisitions where the parties negotiate using industry conventions; cross-checking formal valuation conclusions; valuation disputes where industry practice is relevant evidence.

Limitations: Lacks theoretical rigour — rules of thumb are averages that ignore company-specific factors. Not defensible as a primary valuation method in regulatory or litigation contexts. May be outdated as industry dynamics evolve. Varies by geography — a US rule of thumb may not apply in India.

Method 14: Scorecard Method

Mechanics: Developed by Bill Payne for angel investing. Starts with the average pre-money valuation for comparable startups in the region and adjusts based on weighted scores across factors: management team (0-30%), size of opportunity (0-25%), product/technology (0-15%), competitive environment (0-10%), marketing/sales channels (0-10%), need for additional investment (0-5%), and other factors (0-5%).

Regulatory acceptance: Not prescribed under any Indian statute. Accepted in startup valuation practice and by angel investor networks (Indian Angel Network, Mumbai Angels, Chennai Angels). Used as a supporting method in Rule 11UA DCF reports for pre-revenue startups where DCF projections are inherently speculative.

Ideal use cases: Pre-revenue and early-revenue startups seeking angel investment; seed-stage companies where traditional financial metrics are unavailable; startups applying for DPIIT recognition and tax benefits.

Limitations: Highly subjective — scores depend on the assessor’s judgement. Requires a reliable baseline valuation for the region, which may not be available for all sectors in India. Not defensible as a standalone method for regulatory purposes.

Method 15: Berkus Method

Mechanics: Assigns up to a fixed monetary value (typically up to USD 500K or INR 4 Cr per factor) to five risk-reduction milestones: sound idea (basic value), prototype (technology risk reduction), quality management team (execution risk reduction), strategic relationships (market risk reduction), and product rollout / sales (production risk reduction). Maximum pre-revenue valuation is 5x the per-factor cap.

Regulatory acceptance: Not prescribed under any Indian statute. Used in startup ecosystem as a quick assessment tool. Can serve as a supporting reference in Rule 11UA valuation reports for concept-stage companies where even DCF requires heavy assumptions.

Ideal use cases: Pre-revenue, concept-stage startups; angel round pricing; accelerator/incubator program valuations; DPIIT-recognised startups at ideation stage; internal corporate venturing assessments.

Limitations: Caps are arbitrary and not calibrated for Indian market conditions. Does not account for sector-specific factors or market size. Not appropriate beyond seed stage. Cannot be used as a primary method for any regulatory purpose in India.

Method 16: Risk Factor Summation Method

Mechanics: Starts with a baseline pre-money valuation and adjusts for 12 risk categories: management, stage of business, legislation/political risk, manufacturing risk, sales and marketing risk, funding/capital raising risk, competition, technology risk, litigation risk, international risk, reputation risk, and potential lucrative exit. Each factor is scored from -2 (very negative) to +2 (very positive), with each point adjusting the value by a fixed increment (typically INR 25L to 50L in the Indian context).

Regulatory acceptance: Not prescribed under any statute. Used in angel and VC deal assessment. Acceptable as a supporting method in comprehensive valuation reports, particularly for FEMA pricing of startup shares to foreign investors.

Ideal use cases: Early-stage startups; companies with identifiable but not yet quantified risks; pre-Series A fundraising; valuation reports where a qualitative risk assessment complements the DCF analysis; FDI pricing for startups.

Limitations: Subjective scoring — two valuers may arrive at different scores for the same risk factor. Fixed-increment adjustments are arbitrary. Not suitable as a standalone method for regulatory filings.

Method 17: First Chicago Method

Mechanics: A scenario-based approach that estimates enterprise value under three scenarios — upside (success), base case, and downside (failure/survival) — typically using a DCF or exit-multiple approach for each scenario. Each scenario is assigned a probability weight, and the probability-weighted average yields the final value. Originally developed for venture capital portfolio analysis.

Regulatory acceptance: Recognised under ICAI Valuation Standards as a variant of the income approach. Accepted in IBBI valuation reports. Used in SEBI fairness opinions for transactions involving contingent consideration. Referenced in NCLT proceedings for businesses with uncertain future outcomes.

Ideal use cases: Venture capital and PE portfolio valuations; companies at inflection points (product launches, regulatory approvals); businesses with binary outcomes (pharma with pipeline drugs, infrastructure with pending approvals); startup valuations where a single-scenario DCF is unreliable.

Limitations: Scenario definition and probability assignment are inherently subjective. Requires the valuer to construct three separate financial models. The weighted average can obscure the wide range of potential outcomes — a value of INR 100 Cr (weighted average of 200 Cr upside and 0 downside) has very different risk implications than a value of INR 100 Cr from a stable business.

Method 18: Sum-of-the-Parts (SOTP) / Segment-Based Valuation

Mechanics: Values each business segment, division, or asset class separately using the most appropriate method for that segment, then aggregates to arrive at total enterprise value. Applies different multiples or DCF parameters to each segment based on its risk profile, growth trajectory, and comparable universe. Adds a conglomerate discount (typically 10-25%) where applicable.

Regulatory acceptance: Accepted under ICAI Valuation Standards. Used in SEBI ICDR Regulations for conglomerate companies. Recognised under IBBI Regulations for diversified businesses in CIRP. Mandatory under Ind AS 113 where different valuation techniques are required for different components of value.

Ideal use cases: Diversified conglomerates (Tata, Reliance-type groups); companies with distinct business units operating in different sectors; demerger valuations under Section 232 of the Companies Act; businesses combining operating entities with investment portfolios; schemes of arrangement where each segment has a different acquirer.

Limitations: Ignores synergies between segments (the whole may be worth more or less than the sum of parts). Requires separate comparable analyses for each segment, increasing complexity. Conglomerate discount estimation is subjective. Inter-segment transactions must be eliminated to avoid double-counting.

Decision Tree: How to Select the Right Method

Method selection is not arbitrary — it follows a structured decision tree driven by four primary factors. Our practice at Virtual Auditor applies this decision tree consistently across all valuation engagements:

Factor 1: Regulatory Context

The regulatory framework often mandates or constrains method selection. Always start here:

Regulatory Context	Prescribed Method	Governing Provision
Income Tax — share premium (Section 56(2)(x))	NAV or DCF (by merchant banker / IBBI RV)	Rule 11UA(2)
Income Tax — compulsory acquisition (Section 50CA)	FMV per Rule 11UAA	Rule 11UAA
FEMA — FDI pricing (inbound)	Internationally accepted pricing method (DCF preferred)	FEMA NDI Rules, Rule 21
FEMA — FDI pricing (outbound transfer by NR)	Fair value per internationally accepted methodology	FEMA NDI Rules, Rule 22
IBC — CIRP Resolution Plan	Both Fair Value and Liquidation Value (mandatory)	IBBI CIRP Regulation 35
IBC — Liquidation	Liquidation Value	IBC Section 35
SEBI — Preferential Allotment	VWAP-based floor price	SEBI ICDR Regulations, Chapter V
SEBI — Open Offer / Takeover	Highest of negotiated price, VWAP, highest price paid	SEBI SAST Regulations, Reg 8
Companies Act — Registered Valuer Report	Internationally accepted methodology (ICAI Standards)	Section 247, Companies (RV) Rules
ESOP Valuation (Ind AS 102)	Option pricing model (Black-Scholes / Binomial)	Ind AS 102

Factor 2: Company Stage

The company’s lifecycle stage determines which methods are practically feasible:

Company Stage	Primary Methods	Secondary / Cross-Check
Ideation / Concept (no revenue, no product)	Berkus, Scorecard	Risk Factor Summation
Pre-Revenue (product built, no revenue)	Scorecard, Risk Factor Summation, DCF (scenario-based)	Replacement Cost, Comparable Transactions
Early Revenue (initial traction, pre-profit)	DCF (with Monte Carlo), Revenue Multiples, First Chicago	Comparable Company Analysis, Comparable Transactions
Growth Stage (scaling revenue, approaching profitability)	DCF, Comparable Company Analysis, Revenue / EBITDA Multiples	Comparable Transactions, First Chicago
Mature / Stable (established revenue and profits)	DCF, Capitalisation of Earnings, CCA	NAV, DDM (if dividends paid), SOTP
Distress / Decline	Liquidation Value, NAV	DCF (under turnaround scenario), Comparable Transactions

Factor 3: Purpose of Valuation

The purpose drives the standard of value and therefore the appropriate method:

• Fundraising / Share Issuance: DCF (primary under Rule 11UA), supported by market multiples. Must produce a defensible fair market value that justifies the share premium to the Income Tax Department.
• M&A / Acquisition: DCF + CCA + CTA. Investment value (including synergies) for the acquirer, fair market value for the seller. Fairness opinion for independent directors under Section 177/188.
• FEMA Compliance: DCF as primary method. FEMA pricing must comply with NDI Rules — floor price for inbound FDI (shares cannot be issued below fair value to non-residents), ceiling price for outbound transfer (shares cannot be transferred above fair value by non-residents).
• IBC / Insolvency: Both liquidation value and fair value are mandatory under Regulation 35. The difference between the two enables the CoC to assess the recovery improvement from a going-concern resolution versus liquidation.
• Tax Litigation / Appeals: NAV or DCF per Rule 11UA. Income tax appeal valuations must demonstrate adherence to prescribed methodology and reasonable assumptions.
• ESOP Grants: Fair value per Ind AS 102 — typically Black-Scholes or binomial model. The exercise price determines the perquisite value for employee taxation.
• Financial Reporting: Ind AS 113 fair value hierarchy — Level 1 (quoted prices), Level 2 (observable inputs), Level 3 (unobservable inputs). Method depends on the level of observable market data.

Factor 4: Data Availability

Even the theoretically best method is useless if the required data does not exist:

• No financial projections available: Asset approach (NAV) or market multiples — cannot run DCF without projections.
• No comparable listed companies: DCF as primary, rule of thumb as cross-check — cannot run CCA without peers.
• No comparable transactions: DCF + CCA — cannot run CTA without deal data.
• No audited financials: Scorecard, Berkus, or Risk Factor Summation — quantitative methods require audited numbers.
• No assets on balance sheet: Income approach methods — asset approach will understate value for tech/service companies.

Regulatory Cross-Walk: Same Company, Different Values

A critical concept that many business owners misunderstand is that the same company can have different legitimate values under different regulatory frameworks. This is not manipulation — it reflects different standards of value, different prescribed methods, and different economic assumptions mandated by each framework.

Illustrative Example

Consider a 5-year-old SaaS company with INR 15 Cr ARR, 70% gross margin, 40% YoY growth, negative EBITDA (investing in growth), and INR 3 Cr in net tangible assets:

Regulatory Purpose	Method Used	Indicative Value Range	Reason
Rule 11UA — NAV	Net Asset Value	INR 3-5 Cr	Tangible assets only — ignores SaaS earning power
Rule 11UA — DCF	DCF by IBBI RV	INR 60-90 Cr	Captures future cash flows from ARR growth
FEMA — FDI pricing	DCF (internationally accepted)	INR 60-90 Cr	Similar to Rule 11UA DCF; floor price for NR investor
Market multiples (SaaS comparables)	EV/ARR (8-12x for Indian SaaS)	INR 120-180 Cr	Reflects market pricing for high-growth SaaS
IBC — Liquidation Value	Forced-sale NAV	INR 1-2 Cr	Fire-sale of assets; software has no liquidation value

The valuation ranges from INR 1 Cr (liquidation) to INR 180 Cr (market multiples) — a 180x spread. Each value is correct within its regulatory context. This is precisely why selecting the right method for the right purpose is critical, and why attempting to use a single value across all regulatory contexts invariably creates compliance issues.

Method Selection Matrix: Industry-Specific Guidance

Different industries have different value drivers, and method selection should reflect this reality. Below is our industry-specific guidance based on 100+ engagements at Virtual Auditor:

Technology / SaaS Companies

Primary: DCF (with ARR-based projections) + Revenue Multiples (EV/ARR). Cross-check: CCA with listed SaaS peers (Freshworks, Zoho comparables). Avoid: NAV (significantly understates value). See our dedicated SaaS valuation guide for India-specific ARR multiples and benchmarks.

Manufacturing Companies

Primary: DCF + CCA (EV/EBITDA multiples). Cross-check: NAV (particularly for companies with significant land and plant). Consider: Replacement cost for specialised facilities. Key adjustment: normalise for cyclicality — manufacturing EBITDA margins fluctuate significantly with commodity prices and capacity utilisation.

Real Estate Companies

Primary: NAV (land and property at current market value) + DCF (for development projects using residual land value method). Cross-check: Comparable transaction multiples (price per sq ft of saleable area). Avoid: Capitalisation of earnings (earnings are lumpy and project-dependent).

Financial Services / NBFCs

Primary: DDM + P/BV multiples. Cross-check: Excess return model (ROE vs cost of equity). Avoid: DCF-to-firm (difficult to define free cash flow for financial institutions due to regulatory capital requirements). RBI-regulated entities require additional regulatory overlay.

Pharmaceutical Companies

Primary: SOTP (separate valuation for base business + pipeline). Pipeline: Risk-adjusted DCF or Real Options (probability of regulatory approval × peak sales DCF). Base business: DCF + CCA (EV/EBITDA). Consider: Replacement cost for ANDA/DMF filings and regulatory approvals.

Professional Services Firms

Primary: Capitalisation of earnings + Rule of Thumb (revenue multiples specific to the profession). Cross-check: DCF (based on sustainable billings). Key issue: Personal goodwill vs enterprise goodwill — a significant portion of value may be attributable to key partners and non-transferable.

E-commerce / Marketplace Companies

Primary: DCF (with GMV-based projections) + Revenue Multiples. Cross-check: Comparable transactions (recent funding rounds in the sector). Key metrics: Take rate, GMV growth, customer acquisition cost, contribution margin per order. Avoid: Earnings-based methods if pre-profitability.

Weighting Multiple Methods: The Triangulation Approach

When using multiple methods (which is best practice), the valuer must determine how to weight the results. At Virtual Auditor, we follow a structured triangulation approach:

Equal Weighting

Used when two methods have roughly equal reliability and data quality. Example: mature company valued using both DCF and CCA, where both methods produce values within 15% of each other. Equal weighting (50/50) is appropriate.

Primary-Secondary Weighting

Used when one method is clearly more appropriate but the second provides a useful cross-check. Example: 70% weight to DCF (primary), 30% weight to CCA (cross-check) for a growth-stage company with good projections but limited listed comparables.

Dominant Method with Range Validation

Used when one method is clearly the most appropriate and others serve only to validate the range. Example: 100% weight to DCF for a FEMA pricing report, with CCA and Revenue Multiples used to confirm the DCF conclusion falls within a reasonable market range.

SOTP Aggregation

Used for diversified companies where different methods apply to different segments. Example: DCF for the operating business + NAV for the investment portfolio + Real Options for the development-stage venture. SOTP is an aggregation method, not a weighting method — each segment is valued independently.

Common Errors in Method Selection

Based on our experience reviewing valuation reports in litigation and regulatory proceedings, these are the most common method-selection errors we encounter:

Error 1: Using NAV for Technology Companies Under Rule 11UA

Many valuers default to Rule 11UA(2)(a) NAV for unlisted share valuation because it is simpler. For technology and service companies with minimal tangible assets but significant earning power, NAV materially understates value. This creates problems when shares are issued at a premium — the AO may accept NAV as fair value and treat the excess premium as income under Section 56(2)(x). We always recommend DCF under Rule 11UA(2)(b) for asset-light companies.

Error 2: Using DCF Without Monte Carlo for Startups

A single-scenario DCF for a startup is inherently unreliable — the confidence interval around each projection year widens exponentially. Without Monte Carlo simulation or at least a First Chicago (three-scenario) approach, the valuer cannot demonstrate the robustness of the conclusion. Tax authorities increasingly challenge single-scenario startup DCFs.

Error 3: Ignoring Illiquidity and Minority Discounts

When using CCA (comparing to listed companies), many valuers forget to apply discounts for lack of marketability (DLOM, typically 20-35%) and minority interest (DLOC, typically 15-25% if valuing a minority stake). Failing to apply these discounts overstates value and creates regulatory exposure.

Error 4: Using Revenue Multiples Without Margin Adjustment

A 10x revenue multiple derived from a SaaS company with 80% gross margin and 30% net margin cannot be directly applied to a company with 50% gross margin and negative net margin. Revenue multiples must be adjusted for margin differences — either by using EV/Gross Profit multiples or by deriving implied EV/EBITDA multiples from the comparables.

Error 5: Conflating Fair Value and Investment Value

Fair value (per Ind AS 113 or ICAI Standards) is the price in an orderly transaction between market participants. Investment value includes buyer-specific synergies. Using investment value for a regulatory report that requires fair value will overstate the value. Conversely, using fair value for an acquisition bid may result in losing the deal to a bidder who properly accounts for synergies.

Pricing: What Does a Multi-Method Valuation Cost?

At Virtual Auditor, our valuation pricing depends on the number of methods applied, the complexity of the business, and the regulatory context:

Engagement Type	Methods Typically Used	Indicative Fee Range
Startup Valuation (Rule 11UA / FEMA)	DCF + Scorecard / Revenue Multiple	INR 15,000 – 30,000
SME Business Valuation	DCF + NAV + CCA	INR 30,000 – 75,000
IBC Regulation 35 Valuation	Fair Value (DCF/CCA) + Liquidation Value	INR 75,000 – 2,00,000
ESOP Valuation (Ind AS 102)	Black-Scholes / Binomial + Equity Value (DCF)	INR 20,000 – 50,000
FEMA Valuation (FDI / ODI)	DCF + CCA	INR 25,000 – 60,000
M&A Fairness Opinion	DCF + CCA + CTA + SOTP	INR 1,50,000 – 5,00,000

All engagements include a free initial consultation to determine the appropriate scope and methods before we quote a fixed fee.

How Indian Courts and Tribunals View Valuation Methods

Understanding judicial and quasi-judicial preferences for specific methods is essential for producing valuation reports that withstand regulatory scrutiny:

NCLT / NCLAT (IBC Proceedings)

The NCLT has consistently upheld the Registered Valuer’s method selection where the valuer has clearly documented the rationale. In multiple CIRP proceedings, the NCLT has observed that the CoC’s consideration of both liquidation value and fair value (as required under Regulation 35) is a mandatory procedural safeguard. The NCLAT has set aside resolution plans where the resolution plan value was below liquidation value, emphasising the floor-value function of liquidation valuation.

Income Tax Appellate Tribunal (ITAT)

The ITAT has in several cases accepted DCF valuations under Rule 11UA(2)(b) where the projections were based on reasonable assumptions supported by industry data. Conversely, the ITAT has rejected DCF valuations where (a) projections were not supported by historical performance or industry benchmarks, (b) the discount rate was artificially low, or (c) terminal growth rate exceeded nominal GDP growth. For income tax appeals involving valuation disputes, the quality of assumptions documentation is often the deciding factor.

SEBI Adjudication

SEBI has penalised companies for non-compliance with prescribed pricing methods — particularly in preferential allotment pricing and open offer pricing. The regulator takes a strict view of the prescribed VWAP-based methodology and does not permit alternative methods for floor price computation. Fairness opinions for related-party transactions, however, permit flexibility in method selection.

RBI / FEMA Enforcement

The Enforcement Directorate and RBI scrutinise FEMA pricing valuations for compliance with NDI Rules. The key focus areas are: (a) whether the method used is “internationally accepted,” (b) whether the valuation was conducted by a SEBI-registered merchant banker or a practising Chartered Accountant, and (c) whether the valuation date aligns with the transaction date per the prescribed timelines.

Virtual Auditor’s Multi-Method Engine

Our valuation practice does not default to a single method. For every engagement, we apply the decision tree outlined above and run multiple methods to arrive at a robust, defensible conclusion. Our AI-powered valuation engine automates much of the computational work — WACC calibration, Monte Carlo simulation, comparable screening, sensitivity analysis — allowing our team to focus on the judgement-intensive aspects: assumption validation, method selection rationale, and regulatory compliance.

Every valuation report issued by Virtual Auditor is signed by CA V. Viswanathan (IBBI/RV/03/2019/12333), ensuring compliance with Section 247 of the Companies Act and IBBI Registered Valuer requirements. We maintain professional independence, carry professional indemnity insurance, and follow ICAI Valuation Standards as well as International Valuation Standards (IVS).

Frequently Asked Questions

Virtual Auditor — AI-Powered CA & IBBI Registered Valuer Firm
Valuer: V. VISWANATHAN, FCA, ACS, CFE, IBBI/RV/03/2019/12333
Chennai (HQ): G-131, Phase III, Spencer Plaza, Anna Salai, Chennai 600002
Bangalore: 7th Floor, Mahalakshmi Chambers, 29, MG Road, Bangalore 560001
Mumbai: Workafella, Goregaon West, Mumbai 400062
Phone: +91 99622 60333 | Email: support@virtualauditor.in
Book a Free Consultation